Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genasys (GNSS) Cash & Equivalents (2016 - 2025)

Genasys' Cash & Equivalents history spans 16 years, with the latest figure at $8.0 million for Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 61.15% year-over-year to $8.0 million; the TTM value through Sep 2025 reached $8.0 million, up 61.15%, while the annual FY2025 figure was $8.0 million, 61.15% up from the prior year.
  • Cash & Equivalents for Q3 2025 was $8.0 million at Genasys, up from $5.3 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $18.5 million in Q1 2021 and bottomed at $95000.0 in Q1 2025.
  • The 5-year median for Cash & Equivalents is $8.5 million (2024), against an average of $8.6 million.
  • The largest YoY upside for Cash & Equivalents was 61.15% in 2025 against a maximum downside of 97.32% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $10.1 million in 2021, then decreased by 25.38% to $7.6 million in 2022, then increased by 14.57% to $8.7 million in 2023, then dropped by 2.26% to $8.5 million in 2024, then dropped by 5.9% to $8.0 million in 2025.
  • Per Business Quant, the three most recent readings for GNSS's Cash & Equivalents are $8.0 million (Q3 2025), $5.3 million (Q2 2025), and $95000.0 (Q1 2025).